Lisa Skipper

4.2k total citations · 1 hit paper
20 papers, 3.2k citations indexed

About

Lisa Skipper is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Lisa Skipper has authored 20 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Lisa Skipper's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological diseases and metabolism (8 papers) and Nuclear Receptors and Signaling (7 papers). Lisa Skipper is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological diseases and metabolism (8 papers) and Nuclear Receptors and Signaling (7 papers). Lisa Skipper collaborates with scholars based in United States, Singapore and Norway. Lisa Skipper's co-authors include Mike Hutton, Eng‐King Tan, John Hardy, Dennis W. Dickson, Eileen McGowan, Wen-Lang Lin, Graham L. Jones, Shu‐Hui Yen, Debra Yager and Jada Lewis and has published in prestigious journals such as Science, Nucleic Acids Research and Neuron.

In The Last Decade

Lisa Skipper

20 papers receiving 3.1k citations

Hit Papers

Enhanced Neurofibrillary Degeneration in Transgenic Mice ... 2001 2026 2009 2017 2001 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
    2001 1.2k citations Jada Lewis, Dennis W. Dickson et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Skipper United States 16 1.8k 1.3k 1.1k 937 787 20 3.2k
Jessie Theuns Belgium 30 1.8k 1.0× 1.1k 0.8× 1.5k 1.3× 725 0.8× 463 0.6× 53 3.2k
Yazi D. Ke Australia 28 2.6k 1.4× 781 0.6× 1.6k 1.5× 1.4k 1.5× 850 1.1× 57 4.2k
Isaac Veinbergs United States 21 1.6k 0.9× 1.8k 1.4× 1.1k 1.0× 1.6k 1.7× 696 0.9× 25 3.7k
Robin Barbour United States 23 3.2k 1.8× 1.8k 1.4× 1.8k 1.6× 1.2k 1.3× 820 1.0× 35 5.0k
Toshitaka Kawarai Canada 30 1.4k 0.8× 948 0.7× 1.2k 1.1× 1.0k 1.1× 824 1.0× 75 3.2k
Elena Marcello Italy 32 1.5k 0.8× 431 0.3× 1.3k 1.1× 1.1k 1.2× 722 0.9× 72 3.4k
Christine Stürchler-Pierrat Switzerland 18 3.1k 1.7× 421 0.3× 1.6k 1.4× 1.0k 1.1× 733 0.9× 21 3.9k
Heather L. Melrose United States 29 1.8k 1.0× 1.8k 1.4× 1.2k 1.1× 1.2k 1.3× 764 1.0× 38 3.7k
Hanna Ksiȩżak-Reding United States 35 2.4k 1.3× 856 0.7× 1.7k 1.6× 886 0.9× 756 1.0× 64 3.8k
Catharine Joachim United States 18 2.8k 1.6× 623 0.5× 1.6k 1.5× 642 0.7× 694 0.9× 28 3.7k

Countries citing papers authored by Lisa Skipper

Since Specialization
Citations

This map shows the geographic impact of Lisa Skipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Skipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Skipper more than expected).

Fields of papers citing papers by Lisa Skipper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Skipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Skipper. The network helps show where Lisa Skipper may publish in the future.

Co-authorship network of co-authors of Lisa Skipper

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Skipper. A scholar is included among the top collaborators of Lisa Skipper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Skipper. Lisa Skipper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lappalainen, Ilkka, John Lopez, Lisa Skipper, et al.. (2012). dbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Research. 41(D1). D936–D941. 174 indexed citations
2.
Haugarvoll, Kristoffer, Mathias Toft, Lisa Skipper, et al.. (2008). Fine-mapping and candidate gene investigation within the PARK10 locus. European Journal of Human Genetics. 17(3). 336–343. 27 indexed citations
3.
Ross, Owen A., Adam Braithwaite, Lisa Skipper, et al.. (2008). Genomic investigation of α‐synuclein multiplication and parkinsonism. Annals of Neurology. 63(6). 743–750. 260 indexed citations
4.
Wider, Christian, Lisa Skipper, Alessandra Solida, et al.. (2008). Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism & Related Disorders. 14(6). 465–470. 50 indexed citations
5.
Tan, Eng‐King & Lisa Skipper. (2007). Pathogenic mutations in Parkinson disease. Human Mutation. 28(7). 641–653. 169 indexed citations
6.
Tan, Eng‐King, Lisa Skipper, Louis C.S. Tan, & Jianjun Liu. (2006). LRRK2 G2019S founder haplotype in the Chinese population. Movement Disorders. 22(1). 105–107. 9 indexed citations
7.
Tan, Eng‐King, Lisa Skipper, Meng‐Cheong Wong, et al.. (2006). Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's disease. Movement Disorders. 21(7). 997–1001. 48 indexed citations
8.
Tan, Eng‐King, Yi Zhao, Lisa Skipper, et al.. (2006). The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence. Human Genetics. 120(6). 857–863. 125 indexed citations
9.
Skipper, Lisa, Jianjun Liu, & Eng‐King Tan. (2006). Polymorphisms in candidate genes: implications for the current treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy. 7(7). 849–855. 10 indexed citations
10.
Skipper, Lisa, Yi Li, Carine Bonnard, et al.. (2005). Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Human Molecular Genetics. 14(23). 3549–3556. 62 indexed citations
11.
Tan, Eng‐King, Hui Shen, Louis C.S. Tan, et al.. (2005). The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neuroscience Letters. 384(3). 327–329. 120 indexed citations
12.
McGowan, Eileen, Fiona Pickford, Jungsu Kim, et al.. (2005). Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice. Neuron. 47(2). 191–199. 468 indexed citations
13.
Skipper, Lisa, Hui Shen, E. Chua, et al.. (2005). Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology. 65(8). 1319–1321. 57 indexed citations
14.
Lockhart, Paul J., Mary Hulihan, Sarah Lincoln, et al.. (2004). Identification of the Human Ubiquitin Specific Protease 31 (USP31) Gene: Structure, Sequence and Expression Analysis. DNA sequence. 15(1). 9–14. 18 indexed citations
15.
Skipper, Lisa, Mathias Toft, Matthew Baker, et al.. (2004). Linkage Disequilibrium and Association of MAPT H1 in Parkinson Disease. The American Journal of Human Genetics. 75(4). 669–677. 115 indexed citations
16.
Pals, Philippe, Sarah Lincoln, Jonathan Manning, et al.. (2004). α‐Synuclein promoter confers susceptibility to Parkinson's disease. Annals of Neurology. 56(4). 591–595. 162 indexed citations
17.
Wiley, Joseph, Timothy Lynch, Sarah Lincoln, et al.. (2004). Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with parkin mutations. Movement Disorders. 19(6). 677–681. 13 indexed citations
18.
Farrer, Matthew J., Lisa Skipper, Marianne Berg, et al.. (2002). The Tau H1 Haplotype is associated with Parkinson's disease in the Norwegian population. Neuroscience Letters. 322(2). 83–86. 58 indexed citations
19.
Skipper, Lisa & Matthew J. Farrer. (2002). Parkinson’s Genetics: Molecular Insights for the New Millennium. NeuroToxicology. 23(4-5). 503–514. 13 indexed citations
20.
Lewis, Jada, Dennis W. Dickson, Wen-Lang Lin, et al.. (2001). Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP. Science. 293(5534). 1487–1491. 1203 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessie Theuns Breakdown of academic impact, for papers by Yazi D. Ke Breakdown of academic impact, for papers by Isaac Veinbergs Breakdown of academic impact, for papers by Robin Barbour Breakdown of academic impact, for papers by Toshitaka Kawarai Breakdown of academic impact, for papers by Elena Marcello Breakdown of academic impact, for papers by Christine Stürchler-Pierrat Breakdown of academic impact, for papers by Heather L. Melrose Breakdown of academic impact, for papers by Hanna Ksiȩżak-Reding Breakdown of academic impact, for papers by Catharine Joachim
Rankless by CCL
2026